Cornell Vaginal Ring
Alternative Name: BioRings Intravaginal Ring
Description: A vaginal ring that releases multiple types of non-hormonal agents and microbicides/anti-viral agents, including ferrous gluconate, ascorbic acid, pharmalytes, boclysinated betulonic acid, and tenofovir.
Product Details
User: Female
Hormonal: No
Delivery Method: Vaginal Ring
Duration Type: Short-acting
Duration: 28 days
Regimen: - once per month
- once per month
Active Pharmaceutical Ingredient (API): - tenofovir
- ascorbic acid
- ferrous gluconate
- boclysinated betulonic acid
- tenofovir
- ascorbic acid
- ferrous gluconate
- boclysinated betulonic acid
Inactive material: nanoporous elastomere hydrogel
Multipurpose Preventive Technology (MPT): Yes
Status Details
Developer: BioRings, Weill Cornell Medical College, QPharma
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Pre-clinical
Active Development: Yes
Additional Information
References: Biorings Company Website: http://biorings.com/
2015 Press Release: Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC: www.qpharma.com/20150306%20BioRings%20FINAL.pdf
2009 Press Release: https://techtransfercentral.com/2009/05/27/cornell-researchers-develop-a...
Han YA, et al. (2007) Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents. Contraception. 76(2):132-8.
Biorings Company Website: http://biorings.com/
2015 Press Release: Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC: www.qpharma.com/20150306%20BioRings%20FINAL.pdf
2009 Press Release: https://techtransfercentral.com/2009/05/27/cornell-researchers-develop-a...
Han YA, et al. (2007) Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents. Contraception. 76(2):132-8.